<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate <z:hpo ids='HP_0001909'>leukemia</z:hpo> transformation rate in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and the relationship with quantitative and type of chromosomal abnormality </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: This study retrospectively analyzed and rediagnosed 138 MDS patients with complete data, investigated the rate and time of <z:hpo ids='HP_0001909'>leukemia</z:hpo> transformation, and analyzed characteristics of chromosome karyotype of de novo patients </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: 29 (21.01%) of 138 patients transformed into <z:hpo ids='HP_0001909'>leukemia</z:hpo>, the rate and the median time of <z:hpo ids='HP_0001909'>leukemia</z:hpo> transformation were 21.01% and 8 (3-24) months, respectively, among which, the rate of <z:hpo ids='HP_0001909'>leukemia</z:hpo> transformation in <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype, abnormal karyotype analysis of ≤5 mitotic cells, and &gt;5 mitotic cells in split phase groups were 6.2%, 23.8% and 38.5%, respectively, and median time of which were 17(13-22), 13(5-23), and 7(3-10) months, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Increased trend of <z:hpo ids='HP_0001909'>leukemia</z:hpo> conversion rate along with increased quantity of chromosomal abnormality was observed (χ²=14.185, P＜0.01) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001909'>Leukemia</z:hpo> transformation time negatively correlated with quantity grade of abnormal karyotype (r=-0.631, P&lt;0.01), The <z:hpo ids='HP_0001909'>leukemia</z:hpo> transformation rates in <z:mp ids='MP_0004026'>monosomy</z:mp> 7/del 7q, <z:mp ids='MP_0004027'>trisomy</z:mp> 8, <z:mp ids='MP_0004027'>trisomy</z:mp> 11, complex karyotype and <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype groups were 65.0%, 50.0%, 30.8% and 28.6%, being significantly different (χ²=21.555, P&lt;0.01) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001909'>Leukemia</z:hpo> transformation rate of complex karyotype and <z:mp ids='MP_0004026'>monosomy</z:mp> 7/del 7 q was slightly higher than of <z:mp ids='MP_0004027'>trisomy</z:mp> 8 and <z:mp ids='MP_0004027'>trisomy</z:mp> 11, but both of them were significantly higher than of <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype (χ²=8.054, P=0.005) </plain></SENT>
<SENT sid="6" pm="."><plain>There were no <z:hpo ids='HP_0001909'>leukemia</z:hpo> transformation cases in del 5q, del 20q, <z:mp ids='MP_0004026'>monosomy</z:mp> Y, and <z:mp ids='MP_0004027'>trisomy</z:mp> 21 group </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: With or without abnormal chromosome karyotype, quantity and types of abnormal karyotype had important clinical value to predict <z:hpo ids='HP_0001909'>leukemia</z:hpo> transformation in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>